Clinicians know that complication from stroke in the elderly come

Clinicians know that complication from stroke in the elderly comes not only from the stroke itself but also from the associated comorbidities. So it is not so easy to answer the question, even if many observations both in animal models and in humans have shown that brain plasticity is reduced with aging. Although normal aging is associated with morphological modifications and decline of cerebral functions, it is however accepted that brain plasticity

is probably at least partially preserved in elderly individuals. The capacity of the brain to reorganize after a lesion in order to compensate for a neurological deficit is a major issue for clinicians and for patients, and Inhibitors,research,lifescience,medical is a convincing illustration of brain plasticity. However, brain plasticity is probably more complex and more generally participates in our capacity to interact with the external environment. It is known for example that learning induces changes in the brain circuitry,

and that the acquisition of new skills elicits Inhibitors,research,lifescience,medical diffuse modification in brain neuronal networks. Moreover, it is likely that relearning, which is the basis of rehabilitation procedures in patients with neurological deficits, uses similar principles in lesioned networks of the human brain.7-12 Finally, although plasticity of the human Inhibitors,research,lifescience,medical brain can be investigated through learning about and following up brain lesions, other external agents can play a decisive role in the functional modification of brain neuronal networks. Inhibitors,research,lifescience,medical This is definitely the case for medications. It is clear that Parkinson’s disease provides an excellent example

to demonstrate that the administration of even a single dose of L-DOPA can dramatically change the organization of motor cortices, in particular the supplementary motor area. The question of external modulation of human brain plasticity by drugs or more generally by so-called restorative Inhibitors,research,lifescience,medical therapies has been extensively studied in the past few years, and significant advances have shown that monoaminergic drugs both in animal experiments and in limited Selleck Proteasome inhibitor clinical trials improve recovery crotamiton from focal brain lesions. In particular, a recent clinical study has demonstrated that monoaminergic SSRIs were able to improve motor recovery after stroke. So we now know that drug modulation of human brain plasticity is a reality, and that it opens up new perspectives in the treatment of patients.13-20 We review in this article the main aspects of human brain plasticity as shown in patients with stroke, the drug modulation of brain plasticity and its consequences on recovery, and finally we address the question of the influence of aging on brain plasticity. Brain plasticity after stroke Cellular processes Basic cellular phenomena With respect to outcome, the impact of the different cellular processes that occur during the first days after stroke onset are not yet known.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>